| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arsenic | 91 | 2024 | 151 | 19.430 |
Why?
|
| Arsenicals | 50 | 2023 | 87 | 14.000 |
Why?
|
| Methyltransferases | 32 | 2025 | 66 | 7.750 |
Why?
|
| Arsenites | 41 | 2025 | 54 | 7.620 |
Why?
|
| Escherichia coli | 62 | 2024 | 461 | 6.070 |
Why?
|
| Escherichia coli Proteins | 21 | 2023 | 133 | 4.130 |
Why?
|
| Bacterial Proteins | 33 | 2024 | 580 | 3.810 |
Why?
|
| Roxarsone | 14 | 2024 | 16 | 3.770 |
Why?
|
| Ovarian Neoplasms | 32 | 2022 | 406 | 3.770 |
Why?
|
| Multienzyme Complexes | 25 | 2016 | 69 | 3.210 |
Why?
|
| Ion Pumps | 23 | 2014 | 25 | 3.150 |
Why?
|
| Antimony | 17 | 2024 | 19 | 2.610 |
Why?
|
| Herbicides | 10 | 2021 | 44 | 2.580 |
Why?
|
| S-Adenosylmethionine | 12 | 2022 | 40 | 2.450 |
Why?
|
| Arsenates | 18 | 2024 | 26 | 2.260 |
Why?
|
| Trans-Activators | 13 | 2019 | 190 | 2.060 |
Why?
|
| Aquaglyceroporins | 8 | 2020 | 8 | 1.980 |
Why?
|
| Anti-Bacterial Agents | 13 | 2023 | 415 | 1.980 |
Why?
|
| Drug Resistance, Bacterial | 11 | 2024 | 88 | 1.910 |
Why?
|
| Methylation | 24 | 2025 | 118 | 1.910 |
Why?
|
| Gene Expression Regulation, Bacterial | 10 | 2024 | 168 | 1.870 |
Why?
|
| Pseudomonas putida | 5 | 2023 | 10 | 1.850 |
Why?
|
| Cysteine | 15 | 2021 | 101 | 1.820 |
Why?
|
| Aquaporins | 10 | 2020 | 24 | 1.770 |
Why?
|
| Lyases | 5 | 2022 | 45 | 1.600 |
Why?
|
| Operon | 20 | 2022 | 43 | 1.600 |
Why?
|
| Mutation | 26 | 2022 | 1169 | 1.580 |
Why?
|
| Metallochaperones | 6 | 2012 | 6 | 1.540 |
Why?
|
| Membrane Transport Proteins | 12 | 2024 | 98 | 1.520 |
Why?
|
| Repressor Proteins | 7 | 2021 | 267 | 1.460 |
Why?
|
| Binding Sites | 22 | 2021 | 670 | 1.450 |
Why?
|
| Amino Acid Sequence | 33 | 2024 | 1188 | 1.410 |
Why?
|
| Plant Proteins | 4 | 2015 | 100 | 1.380 |
Why?
|
| Dioxygenases | 4 | 2024 | 12 | 1.340 |
Why?
|
| Biotransformation | 16 | 2019 | 68 | 1.330 |
Why?
|
| Models, Molecular | 22 | 2018 | 875 | 1.320 |
Why?
|
| Bacteria | 10 | 2023 | 285 | 1.280 |
Why?
|
| Shewanella putrefaciens | 3 | 2020 | 3 | 1.230 |
Why?
|
| Adenosine Triphosphatases | 10 | 2020 | 83 | 1.170 |
Why?
|
| Neoplasms, Glandular and Epithelial | 10 | 2017 | 57 | 1.170 |
Why?
|
| Saccharomyces cerevisiae | 13 | 2015 | 199 | 1.150 |
Why?
|
| Burkholderia gladioli | 3 | 2022 | 3 | 1.120 |
Why?
|
| Crystallography, X-Ray | 16 | 2019 | 285 | 1.090 |
Why?
|
| Protein Conformation | 17 | 2021 | 420 | 1.070 |
Why?
|
| Oxidoreductases | 9 | 2023 | 79 | 1.060 |
Why?
|
| Saccharomyces cerevisiae Proteins | 11 | 2015 | 110 | 1.060 |
Why?
|
| Soil Pollutants | 7 | 2016 | 104 | 1.030 |
Why?
|
| Molecular Chaperones | 5 | 2014 | 68 | 1.030 |
Why?
|
| Transcription, Genetic | 7 | 2021 | 599 | 0.970 |
Why?
|
| Genes, BRCA1 | 8 | 2022 | 20 | 0.960 |
Why?
|
| Arsenite Transporting ATPases | 14 | 2009 | 14 | 0.940 |
Why?
|
| Burkholderia | 2 | 2018 | 17 | 0.930 |
Why?
|
| Cacodylic Acid | 4 | 2017 | 5 | 0.900 |
Why?
|
| Molecular Sequence Data | 26 | 2015 | 1559 | 0.890 |
Why?
|
| Comamonas testosteroni | 2 | 2021 | 2 | 0.880 |
Why?
|
| Symporters | 2 | 2023 | 15 | 0.880 |
Why?
|
| Sinorhizobium meliloti | 4 | 2020 | 6 | 0.860 |
Why?
|
| Catalytic Domain | 7 | 2024 | 118 | 0.830 |
Why?
|
| Humans | 83 | 2023 | 42163 | 0.810 |
Why?
|
| Glutaredoxins | 3 | 2014 | 3 | 0.790 |
Why?
|
| Protein Structure, Tertiary | 14 | 2015 | 427 | 0.790 |
Why?
|
| Arsenate Reductases | 8 | 2024 | 8 | 0.770 |
Why?
|
| Carbon | 4 | 2022 | 127 | 0.740 |
Why?
|
| Biological Transport | 18 | 2019 | 201 | 0.740 |
Why?
|
| Biodegradation, Environmental | 11 | 2023 | 82 | 0.740 |
Why?
|
| Glutathione | 3 | 2014 | 170 | 0.730 |
Why?
|
| Biosensing Techniques | 3 | 2014 | 130 | 0.730 |
Why?
|
| Staphylococcus aureus | 4 | 2009 | 91 | 0.720 |
Why?
|
| Sphingobacterium | 1 | 2021 | 1 | 0.720 |
Why?
|
| Genome, Bacterial | 3 | 2024 | 132 | 0.710 |
Why?
|
| Protein Binding | 16 | 2019 | 1076 | 0.700 |
Why?
|
| Metals, Heavy | 4 | 2009 | 69 | 0.700 |
Why?
|
| Animals | 43 | 2023 | 16695 | 0.690 |
Why?
|
| Gynecologic Surgical Procedures | 2 | 2018 | 8 | 0.690 |
Why?
|
| Oxides | 5 | 2022 | 97 | 0.690 |
Why?
|
| Carcinoma | 2 | 2020 | 106 | 0.690 |
Why?
|
| Genetic Predisposition to Disease | 18 | 2022 | 727 | 0.680 |
Why?
|
| Oxidation-Reduction | 11 | 2024 | 448 | 0.680 |
Why?
|
| Conserved Sequence | 5 | 2017 | 121 | 0.650 |
Why?
|
| Amino Acid Substitution | 10 | 2017 | 135 | 0.650 |
Why?
|
| Cystadenocarcinoma, Serous | 6 | 2021 | 44 | 0.630 |
Why?
|
| BRCA2 Protein | 8 | 2022 | 50 | 0.620 |
Why?
|
| Genes, BRCA2 | 6 | 2022 | 12 | 0.610 |
Why?
|
| Sequence Homology, Amino Acid | 12 | 2014 | 271 | 0.610 |
Why?
|
| Corynebacterium glutamicum | 5 | 2019 | 5 | 0.610 |
Why?
|
| Antibiosis | 1 | 2018 | 6 | 0.600 |
Why?
|
| Drug Resistance | 8 | 2016 | 97 | 0.600 |
Why?
|
| Chlamydomonas reinhardtii | 3 | 2016 | 7 | 0.580 |
Why?
|
| Bacillus | 2 | 2017 | 12 | 0.580 |
Why?
|
| Kinetics | 13 | 2024 | 698 | 0.580 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2017 | 209 | 0.570 |
Why?
|
| Adenosine Triphosphate | 6 | 2010 | 205 | 0.570 |
Why?
|
| Mutagenesis, Site-Directed | 12 | 2017 | 189 | 0.560 |
Why?
|
| Breast Neoplasms | 11 | 2022 | 1679 | 0.540 |
Why?
|
| Plasmids | 10 | 2017 | 247 | 0.540 |
Why?
|
| Aspergillus fumigatus | 1 | 2017 | 13 | 0.530 |
Why?
|
| BRCA1 Protein | 6 | 2018 | 58 | 0.520 |
Why?
|
| Genes, Bacterial | 7 | 2021 | 92 | 0.520 |
Why?
|
| Crystallization | 7 | 2014 | 88 | 0.510 |
Why?
|
| Bacteroidetes | 3 | 2025 | 13 | 0.510 |
Why?
|
| Arylsulfatases | 1 | 2016 | 1 | 0.500 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2016 | 8 | 0.500 |
Why?
|
| Bacteroides | 1 | 2016 | 10 | 0.500 |
Why?
|
| Polymorphism, Genetic | 1 | 2017 | 200 | 0.500 |
Why?
|
| Neoadjuvant Therapy | 5 | 2021 | 23 | 0.490 |
Why?
|
| Catalysis | 10 | 2024 | 191 | 0.490 |
Why?
|
| Swine | 4 | 2021 | 205 | 0.480 |
Why?
|
| Chemotherapy, Adjuvant | 5 | 2021 | 53 | 0.480 |
Why?
|
| Adenocarcinoma, Clear Cell | 4 | 2017 | 20 | 0.480 |
Why?
|
| Monosaccharide Transport Proteins | 2 | 2006 | 14 | 0.470 |
Why?
|
| Campylobacter jejuni | 1 | 2015 | 22 | 0.470 |
Why?
|
| Oncology Service, Hospital | 1 | 2015 | 3 | 0.470 |
Why?
|
| Genital Neoplasms, Female | 1 | 2015 | 17 | 0.460 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 60 | 0.460 |
Why?
|
| Female | 44 | 2022 | 24018 | 0.460 |
Why?
|
| Protein O-Methyltransferase | 1 | 2014 | 1 | 0.450 |
Why?
|
| Base Sequence | 10 | 2017 | 997 | 0.450 |
Why?
|
| High-Throughput Screening Assays | 1 | 2015 | 72 | 0.440 |
Why?
|
| Transcription Factors | 7 | 2022 | 722 | 0.440 |
Why?
|
| Actinomycetales | 1 | 2014 | 4 | 0.440 |
Why?
|
| Middle Aged | 30 | 2022 | 11819 | 0.430 |
Why?
|
| Eukaryota | 3 | 2017 | 20 | 0.430 |
Why?
|
| Neoplasm Staging | 9 | 2017 | 366 | 0.430 |
Why?
|
| Growth and Development | 1 | 2014 | 9 | 0.430 |
Why?
|
| Cloning, Molecular | 12 | 2011 | 318 | 0.420 |
Why?
|
| Germ-Line Mutation | 4 | 2022 | 74 | 0.410 |
Why?
|
| Achromobacter | 2 | 2024 | 2 | 0.410 |
Why?
|
| Zinc | 5 | 2009 | 130 | 0.410 |
Why?
|
| Cadmium | 5 | 2009 | 54 | 0.410 |
Why?
|
| cdc25 Phosphatases | 3 | 2010 | 5 | 0.410 |
Why?
|
| Point Mutation | 2 | 2014 | 98 | 0.410 |
Why?
|
| Gene Deletion | 5 | 2021 | 168 | 0.400 |
Why?
|
| Canada | 6 | 2018 | 157 | 0.380 |
Why?
|
| Organic Chemicals | 1 | 2012 | 35 | 0.380 |
Why?
|
| Ovariectomy | 3 | 2020 | 128 | 0.370 |
Why?
|
| Lead | 4 | 2009 | 101 | 0.370 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2021 | 860 | 0.370 |
Why?
|
| Protein Structure, Secondary | 6 | 2015 | 185 | 0.350 |
Why?
|
| Phosphorus | 2 | 2011 | 65 | 0.350 |
Why?
|
| Genetic Association Studies | 4 | 2021 | 118 | 0.350 |
Why?
|
| Streptomyces | 1 | 2011 | 20 | 0.350 |
Why?
|
| Sequence Alignment | 6 | 2016 | 273 | 0.340 |
Why?
|
| Eukaryotic Cells | 4 | 2009 | 36 | 0.340 |
Why?
|
| Glucose Transporter Type 1 | 2 | 2009 | 19 | 0.340 |
Why?
|
| Substrate Specificity | 6 | 2017 | 217 | 0.330 |
Why?
|
| Biological Transport, Active | 4 | 2023 | 27 | 0.330 |
Why?
|
| Aged | 22 | 2022 | 7982 | 0.330 |
Why?
|
| Soil Microbiology | 1 | 2011 | 67 | 0.330 |
Why?
|
| Gram-Positive Bacteria | 2 | 2010 | 18 | 0.330 |
Why?
|
| Dimerization | 6 | 2010 | 115 | 0.330 |
Why?
|
| Ions | 2 | 2007 | 71 | 0.320 |
Why?
|
| Cohort Studies | 9 | 2022 | 1729 | 0.320 |
Why?
|
| Mass Spectrometry | 5 | 2020 | 279 | 0.320 |
Why?
|
| Environmental Pollutants | 1 | 2012 | 198 | 0.320 |
Why?
|
| Oocytes | 4 | 2009 | 147 | 0.300 |
Why?
|
| Adaptation, Biological | 2 | 2020 | 28 | 0.300 |
Why?
|
| Crops, Agricultural | 1 | 2008 | 36 | 0.290 |
Why?
|
| Ion Channels | 3 | 2004 | 74 | 0.290 |
Why?
|
| Aspartic Acid | 1 | 2008 | 51 | 0.290 |
Why?
|
| Survival Rate | 4 | 2017 | 353 | 0.290 |
Why?
|
| Phylogeny | 9 | 2024 | 740 | 0.280 |
Why?
|
| DNA Methylation | 1 | 2012 | 393 | 0.280 |
Why?
|
| Pteris | 1 | 2007 | 5 | 0.280 |
Why?
|
| Retrospective Studies | 7 | 2021 | 2485 | 0.280 |
Why?
|
| Acidithiobacillus thiooxidans | 1 | 2007 | 1 | 0.280 |
Why?
|
| Gene Expression Profiling | 5 | 2024 | 683 | 0.280 |
Why?
|
| Arabidopsis | 4 | 2016 | 102 | 0.280 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 4 | 2014 | 198 | 0.270 |
Why?
|
| Recombinant Proteins | 6 | 2015 | 522 | 0.260 |
Why?
|
| Adult | 23 | 2022 | 13458 | 0.260 |
Why?
|
| DNA-Binding Proteins | 5 | 2019 | 557 | 0.260 |
Why?
|
| Genotype | 6 | 2021 | 796 | 0.260 |
Why?
|
| Arginine | 2 | 2004 | 75 | 0.260 |
Why?
|
| Soil | 6 | 2023 | 170 | 0.250 |
Why?
|
| Fluorescence | 4 | 2015 | 113 | 0.250 |
Why?
|
| Selenium | 1 | 2008 | 150 | 0.250 |
Why?
|
| Phosphates | 4 | 2016 | 54 | 0.250 |
Why?
|
| Mutagenesis | 4 | 2021 | 92 | 0.250 |
Why?
|
| Anti-Infective Agents | 2 | 2019 | 74 | 0.250 |
Why?
|
| Genome-Wide Association Study | 4 | 2015 | 421 | 0.250 |
Why?
|
| Genetic Engineering | 4 | 2014 | 36 | 0.240 |
Why?
|
| Two-Hybrid System Techniques | 4 | 2014 | 51 | 0.240 |
Why?
|
| Promoter Regions, Genetic | 2 | 2014 | 534 | 0.240 |
Why?
|
| Oxalobacteraceae | 2 | 2024 | 2 | 0.240 |
Why?
|
| Adenocarcinoma, Mucinous | 2 | 2017 | 24 | 0.240 |
Why?
|
| Evolution, Molecular | 1 | 2007 | 299 | 0.240 |
Why?
|
| Membrane Proteins | 4 | 2008 | 548 | 0.240 |
Why?
|
| Volatilization | 6 | 2016 | 23 | 0.230 |
Why?
|
| Thioredoxins | 1 | 2025 | 36 | 0.230 |
Why?
|
| Alleles | 4 | 2022 | 352 | 0.220 |
Why?
|
| Endometrial Neoplasms | 2 | 2017 | 79 | 0.220 |
Why?
|
| Genetic Testing | 3 | 2022 | 90 | 0.220 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2020 | 458 | 0.220 |
Why?
|
| Enzyme Activation | 2 | 2015 | 462 | 0.220 |
Why?
|
| Porins | 1 | 2004 | 20 | 0.220 |
Why?
|
| Models, Biological | 5 | 2021 | 711 | 0.220 |
Why?
|
| Epigenesis, Genetic | 2 | 2017 | 274 | 0.210 |
Why?
|
| DNA, Bacterial | 4 | 2018 | 207 | 0.210 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2016 | 190 | 0.210 |
Why?
|
| Genome | 2 | 2021 | 149 | 0.210 |
Why?
|
| Cell Membrane Permeability | 1 | 2004 | 57 | 0.210 |
Why?
|
| Quantitative Trait Loci | 4 | 2018 | 88 | 0.210 |
Why?
|
| DNA | 4 | 2011 | 594 | 0.210 |
Why?
|
| Prognosis | 5 | 2022 | 850 | 0.200 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2003 | 13 | 0.200 |
Why?
|
| Time Factors | 8 | 2014 | 1848 | 0.200 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2006 | 1112 | 0.200 |
Why?
|
| Sulfhydryl Reagents | 2 | 2015 | 6 | 0.200 |
Why?
|
| Metals | 4 | 2019 | 113 | 0.200 |
Why?
|
| DNA Primers | 4 | 2014 | 295 | 0.200 |
Why?
|
| Antiprotozoal Agents | 4 | 2009 | 33 | 0.200 |
Why?
|
| Cation Transport Proteins | 1 | 2002 | 34 | 0.190 |
Why?
|
| Rhizobiaceae | 1 | 2022 | 4 | 0.190 |
Why?
|
| Hydrolysis | 4 | 2007 | 98 | 0.190 |
Why?
|
| Amino Acid Motifs | 3 | 2007 | 94 | 0.190 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2021 | 1 | 0.180 |
Why?
|
| Photosynthesis | 2 | 2012 | 34 | 0.180 |
Why?
|
| Sewage | 1 | 2021 | 27 | 0.180 |
Why?
|
| Ornithine Carbamoyltransferase | 1 | 2021 | 1 | 0.180 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2021 | 3 | 0.170 |
Why?
|
| Water Pollutants, Chemical | 4 | 2018 | 170 | 0.170 |
Why?
|
| Endothelial Cells | 2 | 2021 | 324 | 0.170 |
Why?
|
| Fallopian Tubes | 2 | 2018 | 19 | 0.170 |
Why?
|
| Fabaceae | 2 | 2019 | 29 | 0.170 |
Why?
|
| Fungal Proteins | 2 | 2017 | 143 | 0.170 |
Why?
|
| Nitroreductases | 1 | 2020 | 10 | 0.170 |
Why?
|
| Neoplasm Proteins | 3 | 2022 | 228 | 0.170 |
Why?
|
| Peptidoglycan | 1 | 2020 | 10 | 0.170 |
Why?
|
| Hepatocytes | 1 | 2021 | 79 | 0.170 |
Why?
|
| Risk | 3 | 2015 | 289 | 0.170 |
Why?
|
| Mice | 11 | 2021 | 6490 | 0.170 |
Why?
|
| Plants, Genetically Modified | 3 | 2016 | 50 | 0.170 |
Why?
|
| Enzyme Stability | 2 | 2017 | 35 | 0.160 |
Why?
|
| Oxygen | 2 | 2020 | 217 | 0.160 |
Why?
|
| Alkyl and Aryl Transferases | 1 | 2020 | 15 | 0.160 |
Why?
|
| Mastectomy, Segmental | 2 | 2017 | 25 | 0.160 |
Why?
|
| Heterozygote | 3 | 2015 | 107 | 0.160 |
Why?
|
| Practice Guidelines as Topic | 2 | 2018 | 225 | 0.160 |
Why?
|
| Plant Shoots | 3 | 2011 | 25 | 0.160 |
Why?
|
| Narcotics | 1 | 2020 | 30 | 0.160 |
Why?
|
| Pain, Postoperative | 1 | 2020 | 28 | 0.160 |
Why?
|
| Environmental Exposure | 2 | 2015 | 247 | 0.160 |
Why?
|
| Organometallic Compounds | 1 | 2020 | 72 | 0.160 |
Why?
|
| Nuclear Proteins | 3 | 2017 | 330 | 0.160 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2024 | 36 | 0.160 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2021 | 246 | 0.160 |
Why?
|
| Phenotype | 8 | 2021 | 774 | 0.160 |
Why?
|
| Structure-Activity Relationship | 4 | 2009 | 491 | 0.160 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2011 | 385 | 0.160 |
Why?
|
| Genetic Loci | 2 | 2016 | 102 | 0.150 |
Why?
|
| Mice, Knockout | 4 | 2021 | 1010 | 0.150 |
Why?
|
| Synechocystis | 1 | 2018 | 1 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 3 | 2018 | 454 | 0.150 |
Why?
|
| Osteoporosis | 1 | 2019 | 48 | 0.150 |
Why?
|
| Fallopian Tube Neoplasms | 2 | 2020 | 5 | 0.150 |
Why?
|
| Computer Simulation | 1 | 2021 | 404 | 0.150 |
Why?
|
| Bone Density | 1 | 2019 | 102 | 0.150 |
Why?
|
| Mutant Proteins | 2 | 2009 | 52 | 0.150 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2017 | 358 | 0.150 |
Why?
|
| Temperature | 3 | 2017 | 314 | 0.150 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2018 | 8 | 0.150 |
Why?
|
| Antiporters | 2 | 2011 | 13 | 0.150 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2018 | 11 | 0.150 |
Why?
|
| Follicular Fluid | 1 | 2018 | 5 | 0.150 |
Why?
|
| Sulfhydryl Compounds | 1 | 2018 | 49 | 0.150 |
Why?
|
| Cell Membrane | 5 | 2011 | 400 | 0.140 |
Why?
|
| Drug Resistance, Microbial | 4 | 2007 | 26 | 0.140 |
Why?
|
| Neoplasm, Residual | 2 | 2016 | 15 | 0.140 |
Why?
|
| Carrier Proteins | 2 | 2015 | 318 | 0.140 |
Why?
|
| DNA, Neoplasm | 2 | 2015 | 92 | 0.140 |
Why?
|
| Glutamic Acid | 1 | 2019 | 131 | 0.140 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 2 | 2015 | 17 | 0.140 |
Why?
|
| Microsatellite Instability | 2 | 2017 | 47 | 0.140 |
Why?
|
| Water Microbiology | 1 | 2018 | 82 | 0.140 |
Why?
|
| Dysgerminoma | 1 | 2017 | 1 | 0.140 |
Why?
|
| Gonadoblastoma | 1 | 2017 | 1 | 0.140 |
Why?
|
| Enzyme Inhibitors | 2 | 2020 | 457 | 0.140 |
Why?
|
| Gene Knockout Techniques | 1 | 2017 | 54 | 0.140 |
Why?
|
| Xenopus laevis | 3 | 2009 | 72 | 0.140 |
Why?
|
| Chromosomes, Human, Y | 1 | 2017 | 15 | 0.140 |
Why?
|
| Organoplatinum Compounds | 1 | 2017 | 18 | 0.140 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2017 | 24 | 0.140 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2017 | 32 | 0.130 |
Why?
|
| Sensitivity and Specificity | 3 | 2017 | 602 | 0.130 |
Why?
|
| Embryonic Stem Cells | 1 | 2017 | 55 | 0.130 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 245 | 0.130 |
Why?
|
| Trypsin | 2 | 2008 | 40 | 0.130 |
Why?
|
| Algal Proteins | 2 | 2016 | 3 | 0.130 |
Why?
|
| Metagenomics | 1 | 2017 | 43 | 0.130 |
Why?
|
| Risk Factors | 8 | 2018 | 3942 | 0.130 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2017 | 10 | 0.130 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 153 | 0.130 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2015 | 933 | 0.130 |
Why?
|
| Taxoids | 1 | 2017 | 50 | 0.130 |
Why?
|
| Models, Chemical | 3 | 2006 | 205 | 0.130 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 428 | 0.130 |
Why?
|
| Hormone Replacement Therapy | 1 | 2017 | 49 | 0.130 |
Why?
|
| Protein Subunits | 2 | 2007 | 93 | 0.130 |
Why?
|
| Ontario | 4 | 2019 | 37 | 0.130 |
Why?
|
| Magnesium | 2 | 2008 | 93 | 0.130 |
Why?
|
| Dictyostelium | 1 | 2017 | 48 | 0.130 |
Why?
|
| Anion Exchange Protein 1, Erythrocyte | 1 | 2016 | 6 | 0.130 |
Why?
|
| Odds Ratio | 5 | 2015 | 587 | 0.130 |
Why?
|
| Radiotherapy | 1 | 2016 | 21 | 0.120 |
Why?
|
| Copper | 4 | 2021 | 134 | 0.120 |
Why?
|
| Anaerobiosis | 1 | 2016 | 17 | 0.120 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2016 | 31 | 0.120 |
Why?
|
| Plasmodium berghei | 1 | 2016 | 35 | 0.120 |
Why?
|
| Acetylation | 2 | 2019 | 108 | 0.120 |
Why?
|
| Young Adult | 8 | 2018 | 4936 | 0.120 |
Why?
|
| Amino Acid Transport Systems, Basic | 1 | 1995 | 1 | 0.120 |
Why?
|
| Polynucleotide Adenylyltransferase | 1 | 1995 | 3 | 0.120 |
Why?
|
| Infertility | 1 | 2015 | 21 | 0.120 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2015 | 34 | 0.120 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2016 | 62 | 0.120 |
Why?
|
| Bacillus subtilis | 1 | 2015 | 14 | 0.120 |
Why?
|
| Ferric Compounds | 1 | 2016 | 62 | 0.120 |
Why?
|
| Biological Assay | 1 | 2015 | 63 | 0.120 |
Why?
|
| Nucleotides | 2 | 2006 | 37 | 0.120 |
Why?
|
| Plant Roots | 4 | 2016 | 180 | 0.120 |
Why?
|
| Glucose | 2 | 2009 | 242 | 0.120 |
Why?
|
| Leishmania major | 2 | 2006 | 23 | 0.120 |
Why?
|
| Treatment Outcome | 5 | 2021 | 1586 | 0.120 |
Why?
|
| Cell Lineage | 1 | 2016 | 104 | 0.120 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 122 | 0.120 |
Why?
|
| Embryonic Development | 1 | 2016 | 83 | 0.120 |
Why?
|
| Water Supply | 1 | 2015 | 59 | 0.120 |
Why?
|
| Pseudomonas alcaligenes | 1 | 2015 | 1 | 0.120 |
Why?
|
| NF-kappa B | 1 | 2018 | 355 | 0.120 |
Why?
|
| Aged, 80 and over | 6 | 2018 | 2803 | 0.120 |
Why?
|
| Rats | 4 | 2009 | 3701 | 0.120 |
Why?
|
| Leishmania | 2 | 2005 | 19 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2016 | 150 | 0.110 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2015 | 57 | 0.110 |
Why?
|
| Gene Expression | 3 | 2017 | 692 | 0.110 |
Why?
|
| DNA, Complementary | 2 | 2007 | 195 | 0.110 |
Why?
|
| Epithelial Cells | 1 | 2018 | 426 | 0.110 |
Why?
|
| Rhodopseudomonas | 3 | 2014 | 3 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2017 | 222 | 0.110 |
Why?
|
| Postoperative Period | 1 | 2014 | 33 | 0.110 |
Why?
|
| Ascites | 1 | 2014 | 6 | 0.110 |
Why?
|
| Ultracentrifugation | 1 | 2014 | 14 | 0.110 |
Why?
|
| Patient Selection | 1 | 2016 | 192 | 0.110 |
Why?
|
| Environmental Pollution | 1 | 2014 | 26 | 0.110 |
Why?
|
| Sodium Compounds | 4 | 2009 | 11 | 0.110 |
Why?
|
| Disulfides | 1 | 2015 | 92 | 0.110 |
Why?
|
| Hysterectomy | 1 | 2014 | 39 | 0.110 |
Why?
|
| Food Chain | 2 | 2017 | 20 | 0.110 |
Why?
|
| Poultry | 1 | 2014 | 10 | 0.110 |
Why?
|
| Sequence Analysis, DNA | 2 | 2014 | 508 | 0.110 |
Why?
|
| Mutation, Missense | 1 | 2014 | 88 | 0.110 |
Why?
|
| Genetic Variation | 2 | 2015 | 429 | 0.110 |
Why?
|
| Telomere | 1 | 2014 | 59 | 0.110 |
Why?
|
| Case-Control Studies | 5 | 2015 | 1266 | 0.110 |
Why?
|
| Incidence | 2 | 2014 | 1054 | 0.110 |
Why?
|
| Phosphatidate Phosphatase | 1 | 2013 | 2 | 0.110 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2013 | 3 | 0.110 |
Why?
|
| Telomerase | 1 | 2014 | 42 | 0.100 |
Why?
|
| Cluster Analysis | 1 | 2014 | 206 | 0.100 |
Why?
|
| Organisms, Genetically Modified | 1 | 2013 | 5 | 0.100 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2013 | 47 | 0.100 |
Why?
|
| Carcinogens | 2 | 2004 | 126 | 0.100 |
Why?
|
| Leukocytes | 1 | 2013 | 79 | 0.100 |
Why?
|
| Uterine Neoplasms | 1 | 2014 | 51 | 0.100 |
Why?
|
| Environment | 2 | 2017 | 148 | 0.100 |
Why?
|
| Archaea | 2 | 2017 | 17 | 0.100 |
Why?
|
| Hot Temperature | 2 | 2015 | 141 | 0.100 |
Why?
|
| Fungi | 2 | 2017 | 103 | 0.100 |
Why?
|
| Growth Substances | 1 | 2012 | 16 | 0.100 |
Why?
|
| Gene Targeting | 2 | 2016 | 40 | 0.090 |
Why?
|
| Surface Plasmon Resonance | 1 | 2012 | 35 | 0.090 |
Why?
|
| Risk Assessment | 4 | 2015 | 845 | 0.090 |
Why?
|
| Spectrometry, Fluorescence | 3 | 2007 | 184 | 0.090 |
Why?
|
| Multigene Family | 2 | 2021 | 105 | 0.090 |
Why?
|
| Cyanobacteria | 1 | 2011 | 26 | 0.090 |
Why?
|
| Sodium Selenite | 1 | 2010 | 4 | 0.090 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2010 | 11 | 0.090 |
Why?
|
| Gene Expression Regulation | 3 | 2021 | 1066 | 0.080 |
Why?
|
| X-Ray Absorption Spectroscopy | 1 | 2010 | 7 | 0.080 |
Why?
|
| Tryptophan | 2 | 2008 | 66 | 0.080 |
Why?
|
| Chromosome Mapping | 1 | 2010 | 198 | 0.080 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2010 | 84 | 0.080 |
Why?
|
| Circular Dichroism | 1 | 2010 | 64 | 0.080 |
Why?
|
| Glutamate-Ammonia Ligase | 2 | 2020 | 10 | 0.080 |
Why?
|
| Parasitic Diseases | 1 | 2010 | 6 | 0.080 |
Why?
|
| Registries | 3 | 2018 | 431 | 0.080 |
Why?
|
| Isoenzymes | 1 | 2010 | 169 | 0.080 |
Why?
|
| Lysine | 1 | 2010 | 120 | 0.080 |
Why?
|
| Proportional Hazards Models | 3 | 2017 | 512 | 0.080 |
Why?
|
| Florida | 1 | 2011 | 461 | 0.080 |
Why?
|
| Tamoxifen | 1 | 2009 | 67 | 0.070 |
Why?
|
| Signal Transduction | 1 | 2018 | 2111 | 0.070 |
Why?
|
| Tumor Burden | 2 | 2021 | 84 | 0.070 |
Why?
|
| Genes, Reporter | 2 | 2015 | 148 | 0.070 |
Why?
|
| Membrane Potentials | 2 | 2011 | 221 | 0.070 |
Why?
|
| Cattle | 1 | 2010 | 505 | 0.070 |
Why?
|
| Zebrafish | 1 | 2009 | 146 | 0.070 |
Why?
|
| Antineoplastic Agents | 2 | 2009 | 979 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2002 | 293 | 0.070 |
Why?
|
| Molecular Structure | 1 | 2010 | 560 | 0.070 |
Why?
|
| Chloroplasts | 1 | 2007 | 7 | 0.070 |
Why?
|
| Genes, Plant | 1 | 2008 | 22 | 0.070 |
Why?
|
| Protein Multimerization | 1 | 2009 | 114 | 0.070 |
Why?
|
| Molecular Conformation | 1 | 2008 | 157 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2021 | 1617 | 0.070 |
Why?
|
| Mammals | 1 | 2008 | 109 | 0.070 |
Why?
|
| Structural Homology, Protein | 1 | 2007 | 14 | 0.070 |
Why?
|
| Prokaryotic Cells | 2 | 2009 | 9 | 0.070 |
Why?
|
| Flavoproteins | 1 | 2007 | 16 | 0.070 |
Why?
|
| Absorptiometry, Photon | 1 | 2007 | 74 | 0.070 |
Why?
|
| Xenopus | 2 | 2009 | 47 | 0.070 |
Why?
|
| Survival Analysis | 2 | 2021 | 362 | 0.070 |
Why?
|
| Cytochalasin B | 1 | 2006 | 4 | 0.070 |
Why?
|
| Hexoses | 1 | 2006 | 3 | 0.070 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2006 | 13 | 0.060 |
Why?
|
| Embryo Loss | 1 | 2006 | 4 | 0.060 |
Why?
|
| Protein Transport | 2 | 2009 | 295 | 0.060 |
Why?
|
| Drug Resistance, Fungal | 2 | 2003 | 33 | 0.060 |
Why?
|
| Species Specificity | 2 | 2004 | 279 | 0.060 |
Why?
|
| Antimony Potassium Tartrate | 1 | 2006 | 1 | 0.060 |
Why?
|
| Water | 2 | 2009 | 314 | 0.060 |
Why?
|
| Codon | 1 | 2006 | 40 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2022 | 1574 | 0.060 |
Why?
|
| Oligonucleotides | 1 | 2006 | 54 | 0.060 |
Why?
|
| Protozoan Proteins | 2 | 2005 | 196 | 0.060 |
Why?
|
| Disease-Free Survival | 2 | 2016 | 116 | 0.060 |
Why?
|
| Arabidopsis Proteins | 1 | 2006 | 45 | 0.060 |
Why?
|
| Internet | 2 | 2021 | 234 | 0.060 |
Why?
|
| United States | 4 | 2020 | 5072 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2006 | 154 | 0.060 |
Why?
|
| Cell Division | 2 | 2003 | 314 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2009 | 884 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 3 | 2016 | 1804 | 0.060 |
Why?
|
| DNA Mutational Analysis | 2 | 2015 | 97 | 0.060 |
Why?
|
| Comamonadaceae | 1 | 2024 | 1 | 0.060 |
Why?
|
| Genetic Research | 1 | 2004 | 11 | 0.060 |
Why?
|
| Antimony Sodium Gluconate | 1 | 2004 | 1 | 0.060 |
Why?
|
| Child | 3 | 2021 | 3381 | 0.050 |
Why?
|
| Teratogens | 1 | 2004 | 8 | 0.050 |
Why?
|
| Aspergillus | 1 | 2003 | 12 | 0.050 |
Why?
|
| Flavin-Adenine Dinucleotide | 1 | 2023 | 5 | 0.050 |
Why?
|
| Rhodobacter | 1 | 2023 | 1 | 0.050 |
Why?
|
| Directed Molecular Evolution | 1 | 2003 | 6 | 0.050 |
Why?
|
| Lymphocytes | 1 | 2004 | 124 | 0.050 |
Why?
|
| Cell Line | 2 | 2017 | 1416 | 0.050 |
Why?
|
| Age Factors | 2 | 2018 | 1139 | 0.050 |
Why?
|
| Dipeptides | 1 | 2002 | 31 | 0.050 |
Why?
|
| Staphylococcus | 1 | 2002 | 8 | 0.050 |
Why?
|
| Trace Elements | 1 | 2002 | 34 | 0.050 |
Why?
|
| Membranes | 1 | 2002 | 18 | 0.050 |
Why?
|
| RNA, Complementary | 1 | 2002 | 10 | 0.050 |
Why?
|
| Adaptation, Physiological | 1 | 2003 | 135 | 0.050 |
Why?
|
| Environmental Monitoring | 2 | 2018 | 226 | 0.050 |
Why?
|
| Immunoblotting | 1 | 2002 | 181 | 0.050 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2002 | 19 | 0.050 |
Why?
|
| Genetic Complementation Test | 3 | 2007 | 57 | 0.050 |
Why?
|
| Jews | 1 | 2022 | 6 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2014 | 167 | 0.050 |
Why?
|
| Hydrogen Bonding | 2 | 2014 | 143 | 0.050 |
Why?
|
| Germ Cells | 1 | 2022 | 74 | 0.050 |
Why?
|
| Cytosol | 1 | 2002 | 98 | 0.050 |
Why?
|
| Ecosystem | 1 | 2023 | 171 | 0.040 |
Why?
|
| Flavins | 1 | 2021 | 9 | 0.040 |
Why?
|
| Orotic Acid | 1 | 2021 | 1 | 0.040 |
Why?
|
| Mixed Function Oxygenases | 1 | 2021 | 31 | 0.040 |
Why?
|
| Ammonia | 1 | 2021 | 22 | 0.040 |
Why?
|
| International Cooperation | 1 | 2021 | 51 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2021 | 42 | 0.040 |
Why?
|
| Introns | 1 | 2021 | 80 | 0.040 |
Why?
|
| Information Dissemination | 1 | 2021 | 66 | 0.040 |
Why?
|
| Pregnancy | 2 | 2017 | 1737 | 0.040 |
Why?
|
| Evolution, Planetary | 1 | 2020 | 1 | 0.040 |
Why?
|
| Atmosphere | 1 | 2020 | 3 | 0.040 |
Why?
|
| Fossils | 1 | 2020 | 13 | 0.040 |
Why?
|
| Nerve Block | 1 | 2020 | 5 | 0.040 |
Why?
|
| Mastectomy | 1 | 2020 | 16 | 0.040 |
Why?
|
| Europe | 2 | 2014 | 114 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2020 | 74 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2002 | 973 | 0.040 |
Why?
|
| Acidithiobacillus | 1 | 2019 | 4 | 0.040 |
Why?
|
| Mycobacterium bovis | 1 | 2019 | 14 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2020 | 300 | 0.040 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2019 | 34 | 0.040 |
Why?
|
| Heredity | 1 | 2018 | 7 | 0.040 |
Why?
|
| Monosaccharides | 1 | 2018 | 13 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2020 | 181 | 0.040 |
Why?
|
| Pedigree | 1 | 2018 | 94 | 0.040 |
Why?
|
| Argentina | 1 | 2018 | 14 | 0.040 |
Why?
|
| Male | 4 | 2022 | 22779 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2019 | 232 | 0.040 |
Why?
|
| Adolescent | 3 | 2018 | 5950 | 0.040 |
Why?
|
| Guideline Adherence | 1 | 2018 | 98 | 0.040 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 2 | 2010 | 6 | 0.030 |
Why?
|
| Mosaicism | 1 | 2017 | 7 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2017 | 30 | 0.030 |
Why?
|
| Serine | 1 | 2017 | 81 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2015 | 2598 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 438 | 0.030 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2017 | 61 | 0.030 |
Why?
|
| Epidemiologic Factors | 1 | 2017 | 3 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2017 | 165 | 0.030 |
Why?
|
| Brachytherapy | 1 | 2017 | 11 | 0.030 |
Why?
|
| DNA Mismatch Repair | 1 | 2017 | 28 | 0.030 |
Why?
|
| Neoplasms, Second Primary | 1 | 2017 | 15 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 143 | 0.030 |
Why?
|
| Microbial Viability | 1 | 2017 | 42 | 0.030 |
Why?
|
| Reproductive History | 1 | 2017 | 27 | 0.030 |
Why?
|
| Parity | 1 | 2017 | 60 | 0.030 |
Why?
|
| Ovary | 1 | 2017 | 112 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2016 | 23 | 0.030 |
Why?
|
| Erythropoiesis | 1 | 2016 | 11 | 0.030 |
Why?
|
| Radiotherapy Dosage | 1 | 2016 | 8 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 2016 | 13 | 0.030 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2016 | 7 | 0.030 |
Why?
|
| Mice, Inbred CBA | 1 | 2016 | 41 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2016 | 81 | 0.030 |
Why?
|
| Insemination, Artificial | 1 | 2015 | 10 | 0.030 |
Why?
|
| Fertility Agents, Female | 1 | 2015 | 8 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2016 | 44 | 0.030 |
Why?
|
| Infusions, Parenteral | 1 | 2015 | 13 | 0.030 |
Why?
|
| DNA, Fungal | 1 | 2015 | 47 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2014 | 1265 | 0.030 |
Why?
|
| Nuchal Cord | 1 | 2015 | 2 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 2015 | 31 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2015 | 55 | 0.030 |
Why?
|
| Maximum Allowable Concentration | 1 | 2015 | 2 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2017 | 284 | 0.030 |
Why?
|
| Host-Parasite Interactions | 1 | 2016 | 75 | 0.030 |
Why?
|
| Carboplatin | 1 | 2015 | 20 | 0.030 |
Why?
|
| Breast | 1 | 2017 | 139 | 0.030 |
Why?
|
| Fertilization in Vitro | 1 | 2015 | 57 | 0.030 |
Why?
|
| Cell Survival | 1 | 2019 | 934 | 0.030 |
Why?
|
| Fertility | 1 | 2015 | 63 | 0.030 |
Why?
|
| beta-Galactosidase | 1 | 1995 | 37 | 0.030 |
Why?
|
| Government Regulation | 1 | 2015 | 15 | 0.030 |
Why?
|
| Blastocyst | 1 | 2016 | 50 | 0.030 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2015 | 71 | 0.030 |
Why?
|
| beta-Lactamases | 1 | 1995 | 34 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 236 | 0.030 |
Why?
|
| Food Contamination | 1 | 2015 | 55 | 0.030 |
Why?
|
| Iron | 1 | 2017 | 247 | 0.030 |
Why?
|
| Morbidity | 1 | 2015 | 97 | 0.030 |
Why?
|
| Protein Engineering | 1 | 2015 | 47 | 0.030 |
Why?
|
| Paclitaxel | 1 | 2015 | 64 | 0.030 |
Why?
|
| Cisplatin | 1 | 2015 | 91 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2015 | 173 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 1058 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 1554 | 0.030 |
Why?
|
| Chromosomes, Bacterial | 1 | 2014 | 21 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 144 | 0.030 |
Why?
|
| Gene Expression Regulation, Plant | 2 | 2007 | 65 | 0.030 |
Why?
|
| Syndrome | 1 | 2014 | 73 | 0.030 |
Why?
|
| Microsatellite Repeats | 1 | 2014 | 60 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2014 | 64 | 0.030 |
Why?
|
| Peritoneal Neoplasms | 1 | 2014 | 18 | 0.030 |
Why?
|
| Baltimore | 1 | 2014 | 58 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 1051 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 638 | 0.030 |
Why?
|
| North America | 1 | 2014 | 85 | 0.030 |
Why?
|
| Immunity | 1 | 2014 | 60 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2016 | 303 | 0.030 |
Why?
|
| Republic of Korea | 1 | 2014 | 133 | 0.030 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2013 | 3 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2014 | 203 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 577 | 0.030 |
Why?
|
| Community-Institutional Relations | 1 | 2015 | 208 | 0.030 |
Why?
|
| Japan | 1 | 2014 | 348 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2016 | 633 | 0.020 |
Why?
|
| Logistic Models | 1 | 2015 | 1001 | 0.020 |
Why?
|
| Internationality | 1 | 2012 | 38 | 0.020 |
Why?
|
| Enzymes, Immobilized | 1 | 2012 | 13 | 0.020 |
Why?
|
| Biocatalysis | 1 | 2011 | 30 | 0.020 |
Why?
|
| Brain | 1 | 2020 | 1452 | 0.020 |
Why?
|
| Public Health | 1 | 2015 | 405 | 0.020 |
Why?
|
| Protons | 1 | 2011 | 94 | 0.020 |
Why?
|
| Nigericin | 1 | 2010 | 1 | 0.020 |
Why?
|
| Formates | 1 | 2010 | 6 | 0.020 |
Why?
|
| Lactates | 1 | 2010 | 9 | 0.020 |
Why?
|
| Pyruvic Acid | 1 | 2010 | 21 | 0.020 |
Why?
|
| Solutions | 1 | 2010 | 65 | 0.020 |
Why?
|
| Gold | 1 | 2012 | 153 | 0.020 |
Why?
|
| Mercury | 1 | 2010 | 39 | 0.020 |
Why?
|
| Permeability | 1 | 2009 | 66 | 0.020 |
Why?
|
| Ion Transport | 1 | 2009 | 22 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 254 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 1 | 2009 | 30 | 0.020 |
Why?
|
| Lethal Dose 50 | 1 | 2009 | 32 | 0.020 |
Why?
|
| Heart Conduction System | 1 | 2009 | 15 | 0.020 |
Why?
|
| Glycerol | 1 | 2009 | 34 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2009 | 141 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2009 | 230 | 0.020 |
Why?
|
| Helium | 1 | 2008 | 2 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2009 | 184 | 0.020 |
Why?
|
| Microbiology | 1 | 2008 | 2 | 0.020 |
Why?
|
| Chromatography | 1 | 2008 | 17 | 0.020 |
Why?
|
| Chromatography, Gas | 1 | 2008 | 16 | 0.020 |
Why?
|
| Gases | 1 | 2008 | 25 | 0.020 |
Why?
|
| Equipment Design | 1 | 2008 | 143 | 0.020 |
Why?
|
| Industrial Waste | 1 | 2007 | 16 | 0.020 |
Why?
|
| NADP | 1 | 2007 | 37 | 0.020 |
Why?
|
| Flavin Mononucleotide | 1 | 2007 | 9 | 0.020 |
Why?
|
| Nitrogen | 1 | 2008 | 83 | 0.020 |
Why?
|
| Myocardium | 1 | 2009 | 251 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 928 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2007 | 78 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2007 | 193 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2012 | 449 | 0.020 |
Why?
|
| Exons | 1 | 2006 | 91 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2006 | 96 | 0.020 |
Why?
|
| Parasitic Sensitivity Tests | 1 | 2005 | 14 | 0.020 |
Why?
|
| Azides | 1 | 2005 | 10 | 0.010 |
Why?
|
| Thrombin | 1 | 2005 | 28 | 0.010 |
Why?
|
| RNA Interference | 1 | 2006 | 246 | 0.010 |
Why?
|
| K562 Cells | 1 | 2004 | 32 | 0.010 |
Why?
|
| HL-60 Cells | 1 | 2004 | 33 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2005 | 95 | 0.010 |
Why?
|
| Sulfates | 1 | 2004 | 26 | 0.010 |
Why?
|
| Leishmaniasis | 1 | 2004 | 7 | 0.010 |
Why?
|
| DNA, Protozoan | 1 | 2004 | 27 | 0.010 |
Why?
|
| Sister Chromatid Exchange | 1 | 2004 | 6 | 0.010 |
Why?
|
| Spectrum Analysis | 1 | 2004 | 59 | 0.010 |
Why?
|
| Valinomycin | 1 | 2003 | 1 | 0.010 |
Why?
|
| Uncoupling Agents | 1 | 2003 | 2 | 0.010 |
Why?
|
| Verapamil | 1 | 2003 | 7 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2004 | 96 | 0.010 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2003 | 33 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 2004 | 61 | 0.010 |
Why?
|
| Molecular Weight | 1 | 2003 | 168 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 65 | 0.010 |
Why?
|
| Transfection | 1 | 2004 | 526 | 0.010 |
Why?
|
| Luminescent Measurements | 1 | 2003 | 26 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2003 | 223 | 0.010 |
Why?
|
| Transformation, Genetic | 1 | 2002 | 21 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2003 | 207 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 2002 | 26 | 0.010 |
Why?
|
| Saccharomyces | 1 | 2002 | 1 | 0.010 |
Why?
|
| Refuse Disposal | 1 | 2002 | 17 | 0.010 |
Why?
|
| Vitamin D | 1 | 2004 | 196 | 0.010 |
Why?
|
| Dithiothreitol | 1 | 2002 | 18 | 0.010 |
Why?
|
| Reference Values | 1 | 2002 | 207 | 0.010 |
Why?
|
| Cations, Divalent | 1 | 2002 | 25 | 0.010 |
Why?
|
| Nickel | 1 | 2002 | 22 | 0.010 |
Why?
|
| Computational Biology | 1 | 2004 | 324 | 0.010 |
Why?
|
| Plant Leaves | 1 | 2002 | 134 | 0.010 |
Why?
|